Initially, the catalytic activities of all the designed DNAzymes against MAPT mRNA were screened in SH-SY5Y neuroblastoma cells by transfecting at two different concentrations (400 and 50 nM) for 24 h. Here, MAPT is linked to neuroblastoma.